Search Thermo Fisher Scientific
Search Thermo Fisher Scientific
RNA analysis has been a key infectious disease research and testing. There are several ways for quantifying cellular RNA, each with its own set of benefits and drawbacks. One method may be better than the other depending on the nature of the experiment and the real scientific issues asked. Besides research and testing, RNA technology has also advanced into therapeutic applications.
Compared with traditional and recombinant protein vaccines, mRNA is transcribed and synthesized in vitro, which has obvious advantages in its development cycle and production cycle and has become a new hope for fighting against large-scale explosive infectious diseases. Thermo Fisher can provide an overall solution from identification, production, and purification to delivery of mRNAs. As a professional raw material supplier, Thermo Fisher can also provide complete OEM solutions for in vitro transcription to better meet customers’ needs for free of animal-origin ingredients and antibiotics, and a wider range of quality inspections.
In this collection of webinars, researchers demonstrate how NGS can be used to interrogate the SARS-CoV-2 genome across multiple samples simultaneously for contact tracing and to rapidly obtain a global picture for surveillance, as well as other applications such as phylogenetic analysis, viral typing, and environmental monitoring.
Accelerated development of mRNA-based vaccine has necessitated the transformation of standard, research grade in vitro transcription reagents into raw material specifically designed and manufactured under advanced quality standards. The TheraPure grade reagents for mRNA-based vaccine represents Thermo Fisher Scientific’s highest level of purity for mRNA synthesis reagents, with products manufactured using high-definition analytics and tightly controlled purity standards. The TheraPure grade portfolio offers a unique integrated solution for mRNA synthesis, including animal origin-free and ampicillin-free enzymes.